# Chemcon Speciality Chemicals share price today (Chemcon Speciality Chemicals Ltd, NSE: CHEMCON)

> Chemcon Speciality Chemicals share price today: ₹193.84 at the NSE close on 4 November 2026, down 18.4% in a year. Chemcon Speciality Chemicals (NSE: CHEMCON) is worth ₹709 crore, trades at a P/E of 23.6 and has closed between ₹134.05 and ₹237.59 over the past 52 weeks. > Chemcon Speciality Chemicals Ltd's results are improving, while its P/E is near the low end of its own history over 6.1 years, higher than only 30% of past readings. CHEMCON · Speciality Chemicals · data as of 4 November 2026. Page: https://www.sectoralpha.in/stocks/chemcon-speciality-chemicals-ltd

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Mixed, from the last 12 quarters
- Price: ₹193.84 (−18.4% in a year)
- P/E: 23.6× (lower than 70% of the last 6.1 years)
- Revenue (Sep 2026): ₹65.5 Cr (+21.9% on a year ago)
- Profit (Sep 2026): ₹7.5 Cr (+30.8% on a year ago)
- Operating margin: 16.9% (+4.1 points on a year ago)
- ROCE: 6%, FY26
- ROIC: 6.5%, against a 12.0% cost of capital: −5.5 points

Biggest thing to watch: the price has already been rising for 8 weeks, so timing is the risk more than the business. ## What is the Chemcon Speciality Chemicals share price today? Chemcon Speciality Chemicals Ltd's share price was ₹193.84 at the close on 4 November 2026. It has been rising for 8 weeks. That is 1.1% below its average price over the last 200 trading days. In the last 52 weeks it traded between ₹134 and ₹238, and at that close it sat 58% of the way up from that low. Over the past 13 weeks it has done better than the NIFTY 500, and it has stayed ahead for 11 weeks in a row. Over the last 6.1 years the share price moved −67% while the NIFTY 500 moved +127%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What changed at Chemcon Speciality Chemicals this quarter? 1 points on a year earlier. 1. Revenue up on a year earlier for 6 quarters in a row In the September 2026 quarter revenue was ₹65 crore, +21.9% on a year earlier. 2. Operating margin up 4.1 points on a year earlier 16.9% in the September 2026 quarter, from 12.8%. ## What dividend does Chemcon Speciality Chemicals pay? Chemcon Speciality Chemicals paid ₹6.50 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 3.35% at the ₹193.84 close on 4 November 2026. The last was an interim dividend of ₹6.50 a share, ex-date 27 May 2026. ### Chemcon Speciality Chemicals dividends since 1 April 2021

| Ex-date | Dividend per share | Type | Record date |
| --- | --- | --- | --- |
| 27 May 2026 | ₹6.50 | Interim | 28 May 2026 |
| 22 Aug 2022 | ₹4 | Interim | 23 Aug 2022 |

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. 1 of 5 Of the last 5 financial years, years with an NSE dividend record

Yes. Chemcon Speciality Chemicals Ltd paid out 101% of its profit as dividends in FY26, and it paid a dividend in 2 of its last 13 reported years. (From the NSE corporate-actions record, read 5 November 2026.)

## What are Chemcon Speciality Chemicals' latest quarterly results? For July to September 2026 (the quarter ended 30 September 2026), Chemcon Speciality Chemicals reported revenue of ₹65.5 crore, up 21.9% from ₹53.7 crore a year earlier, and a profit of ₹7.52 crore, up 30.8% from ₹5.75 crore. ### Chemcon Speciality Chemicals results: July to September 2026 against a year earlier

| Measure | July to September 2026 | July to September 2025 | Change |
| --- | --- | --- | --- |
| Revenue | ₹65.5 crore | ₹53.7 crore | +21.9% |
| Profit | ₹7.52 crore | ₹5.75 crore | +30.8% |
| Earnings per share | ₹2.05 | ₹1.57 | +30.6% |
| Operating margin | 16.9% | 12.8% | +4.1 points |

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter). The newest call in our records is from 9 November 2023, about July to September 2023; a call about these results is not in our records yet. (From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.)

## What is the Chemcon Speciality Chemicals share price history? Chemcon Speciality Chemicals closed at ₹193.84 on 4 November 2026, down 18.4% from ₹237.59 a year earlier (7 November 2025) and down 52.3% over five years. Its highest weekly close since October 2020 was ₹584.80 on 1 October 2020. ### Chemcon Speciality Chemicals share price: then and now

| When | Close | Change to 4 Nov 2026 |
| --- | --- | --- |
| 1 week ago · 30 Oct 2026 | ₹181.84 | +6.6% |
| 1 month ago · 1 Oct 2026 | ₹215.93 | −10.2% |
| 6 months ago · 8 May 2026 | ₹178.48 | +8.6% |
| 1 year ago · 7 Nov 2025 | ₹237.59 | −18.4% |
| 3 years ago · 3 Nov 2023 | ₹268.95 | −27.9% |
| 5 years ago · 4 Nov 2021 | ₹406.20 | −52.3% |
| Earliest and highest weekly close in our records · 1 Oct 2020 | ₹584.80 | −66.9% |
| Lowest weekly close since October 2020, also the 52-week low · 27 Mar 2026 | ₹134.05 | +44.6% |
| 52-week high (weekly close) · 7 Nov 2025 | ₹237.59 | −18.4% |

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes. (322 weekly closes from 1 October 2020 to 4 November 2026.)

## What is the latest news on Chemcon Speciality Chemicals? 4 Nov 2026: Chemcon Speciality Chemicals closed at ₹193.84, up 6.6% on the week and down 10.2% on the month. Results for July to September 2026: Revenue up 21.9% and profit up 30.8% on a year earlier. ### Earlier

- 27 May 2026: ex-date for an interim dividend of ₹6.50 a share, record date 28 May 2026. - 9 Nov 2023: Chemcon Speciality Chemicals held its results call for July to September 2023. ## What did Chemcon Speciality Chemicals management say on the latest results call? On the call for July to September 2023, held on 9 November 2023, Chemcon Speciality Chemicals' management spoke about the quarter; the main points are below. Source: [the call transcript](https://files.tijorifinance.com/insight/india/37353/Conference Call/CC-Sep23.pdf). (From the call for July to September 2023, 9 November 2023. The July to September 2026 results are out since, so this part may be out of date until we update it.)

## Which stock lists is Chemcon Speciality Chemicals on? Chemcon Speciality Chemicals is on one of our India lists: Dividend stocks. [Dividend stocks Regular dividend yield (%): 3.35](https://www.sectoralpha.in/dividend-stocks-india)

## Is Chemcon Speciality Chemicals profitable? Chemcon Speciality Chemicals Ltd earned ₹7.5 Cr of net profit in the Sep 2026 quarter, +30.8% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹24.0 Cr. Over 10 years profit has grown 23.1% a year on average. That is 11.5% of the quarter's revenue. The same quarter a year earlier earned ₹5.8 Cr. For the full year, FY26 profit was ₹24.0 Cr (+0.0% on the year before). Why profit moved: revenue changed +21.9% on a year earlier and the margin moved +4.1 percentage points. Most of the change came from keeping more of each sale. On average over the last four quarters, profit changed +30.3% and revenue +22.2%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit. ## How much revenue does Chemcon Speciality Chemicals make, and is it growing? Chemcon Speciality Chemicals Ltd reported ₹65.5 Cr of revenue in the Sep 2026 quarter, +21.9% on the same quarter a year earlier. That is the 6th quarter in a row with growth on the year before. Over 10 years it has grown 9.5% a year on average. The last full year, FY26, came in at ₹240 Cr. The last four reported quarters add to ₹265 Cr. FY26 revenue was ₹240 Cr, +15.9% on the year before. Recent pace: the last four quarters grew +22.2% on average, against 9.5% a year over the longer run, so this year is growing faster than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +22.3%, against +12.1% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +20.2%, against +25.4% a year (rolling over). ## How much of every ₹100 of sales does Chemcon Speciality Chemicals keep? Chemcon Speciality Chemicals Ltd's operating margin was 16.9% in the Sep 2026 quarter, 4.1 percentage points higher than the same quarter a year ago. Across 13 years it has been between 10.0% and 33.0%. The latest quarter is within that range. Why the margin moved: operating margin changed +4.1 percentage points on the year while gross margin changed +2.4 points. So the gain came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Chemcon Speciality Chemicals' profit turning into cash? Over the last 3 years, 137% of Chemcon Speciality Chemicals Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹42.0 Cr of operating cash against ₹24.0 Cr of profit. After ₹39.0 Cr of spending on assets, ₹3.0 Cr was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why 137% of profit came in as cash: the cash cycle got 38 days shorter between FY21 and FY26, so cash that used to wait in the business now arrives sooner. What to look at next: the bigger use of cash is spending on new assets, at 2.8× depreciation over three years. The next section checks what that spending is building. ## Where does Chemcon Speciality Chemicals' cash go? Chemcon Speciality Chemicals Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 212 days in FY26, down from 250 days in FY21. It spent ₹94.0 Cr on assets over the last 3 years. Customers take 97 days to pay, and stock sits for 158 days on average. At FY26 sales of ₹240 Cr, each day of that cycle ties up about ₹0.7 Cr, so roughly ₹139 Cr is tied up in the business at any time. FY26: customers took 97 days to pay and stock sat for 158 days, about 5.2 months of sales sitting as stock, for a full cycle of 212 days, shorter than FY21's 250. The full loop: cash goes out to suppliers and production on day 0. Stock sits for 158 days. Customers pay about 97 days after that. Suppliers are paid at 42 days. Together that makes the 212-day cycle. Spending on assets: ₹94.0 Cr over the last 3 years, against ₹33.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹21.0 Cr (FY26): assets paid for that are not earning yet. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Chemcon Speciality Chemicals' P/E ratio, and how does it compare with its own history? Chemcon Speciality Chemicals Ltd's P/E is 23.6×, near the low end of its own history: it has been lower only 30% of the time. Its usual P/E (the middle reading) is 28.9×, over 6.1 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −3.4% while the price moved −18.4%. Earnings did better than the price, which pulled the multiple down within its own range. Where the price move came from: over 5 years the price moved −13.8% a year; about −12.9% a year came from earnings growth and about −0.9 percentage points from the multiple (roughly no change). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple. In short: the multiple is low against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Chemcon Speciality Chemicals business getting better or worse? Chemcon Speciality Chemicals Ltd's business is giving mixed signals. There is no clear direction across the growth lines, with ROCE steady at 8.7%; each line tells part of the story. This is based on 12 quarters of 4 measures. Why it matters: when the lines disagree, each line above matters more than any single label. ## How much does Chemcon Speciality Chemicals earn on its capital? Chemcon Speciality Chemicals Ltd earned a ROCE of 6% in FY26. Its return on capital used (ROIC) is 5.5 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 10.0% net margin and 0.42× asset turnover (sales divided by assets). Why the return is what it is (FY26): a 10.0% net margin × 0.42× asset turnover × 1.17× leverage (assets divided by equity) ≈ 4.9% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: 6.5% − 12.0% = −5.5 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The 6.5% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 2.9%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Chemcon Speciality Chemicals have too much debt? Chemcon Speciality Chemicals Ltd has total debt of ₹27.0 Cr against shareholder equity of ₹478 Cr as of Sep 2026, so its debt is 0.06× its equity, which is very little. Year by year, that ratio went from 0.09 in FY22 to 0.11 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Chemcon Speciality Chemicals shareholding pattern? No group of Chemcon Speciality Chemicals Ltd's owners changed its stake by a full percentage point over the last two years. Promoters moved +0.0 points over the same period, to 74.5%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings. Over the last two years: Domestic institutions: −0.3 points over 8 quarters, to 0.0%; Promoters: +0.0 points over 8 quarters, to 74.5%; Foreign institutions: +0.0 points over 8 quarters, to 0.3%. ## How far is Chemcon Speciality Chemicals from balance-sheet trouble? For Chemcon Speciality Chemicals Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Chemcon Speciality Chemicals rank in its industry? 50.9 out of 100, rank 17 of 30 in Speciality Chemicals, with 85% of the evidence available. Chemcon Speciality Chemicals Ltd scores 50.9 out of 100 against the 30 companies it is compared with in Speciality Chemicals, ranking 17. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 24.6 + 8.6 + 7.9 + 9.8 = 50.9. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Chemcon Speciality Chemicals compared with? Chemcon Speciality Chemicals ranks 17 of 30 Speciality Chemicals companies on the 4-Factor Sector Score, with 50.9 out of 100. 1. [Panama Petrochem Ltd](https://www.sectoralpha.in/stocks/panama-petrochem-ltd) PANAMAPET · turning · Sector-leading setup · 96% evidence 82.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.8/35 · Revenue 45.9% · Profit 100% · Operating margin change 14 points · 88% evidence Capital efficiency 17.6/25 · ROCE 19.2% · Operating margin 22% · 100% evidence Valuation 19.7/20 · P/E 5.7× · PEG 0.18 · 100% evidence Relative strength 13.9/20 · Lead over its industry 16.3% · Lead over NIFTY 500 31.3% · 1 year 68.1% · 100% evidence · 10 of 12 weeks ahead Exact sum: 30.8 + 17.6 + 19.7 + 13.9 = 82 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [Yasho Industries Ltd](https://www.sectoralpha.in/stocks/yasho-industries-ltd) YASHO · losing its lead · Most evidence points up · 78% evidence 67.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 30.0/35 · Revenue 54.2% · Profit 100% · Operating margin change 3 points · 100% evidence Capital efficiency 12.3/25 · ROCE 8.9% · Operating margin 21% · 100% evidence Valuation 12.7/20 · P/E 45× · PEG 1.02 · 65% evidence Relative strength 12.2/20 · Lead over its industry n/a · Lead over NIFTY 500 41.1% · 1 year 103.4% · 25% evidence · 11 of 12 weeks ahead Exact sum: 30 + 12.3 + 12.7 + 12.2 = 67.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Vikram Thermo (India) Ltd](https://www.sectoralpha.in/stocks/vikram-thermo-indialtd) breaking out · Evidence leans up · 68% evidence 64.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.8/35 · Revenue 16.9% · Profit 41.9% · Operating margin change 8 points · 83% evidence Capital efficiency 21.1/25 · ROCE 36.2% · Operating margin 48% · 95% evidence Valuation 6.6/20 · P/E 25.8× · PEG n/a · 50% evidence Relative strength 12.5/20 · Lead over its industry n/a · Lead over NIFTY 500 74.5% · 1 year n/a · 25% evidence · 12 of 12 weeks ahead Exact sum: 23.8 + 21.1 + 6.6 + 12.5 = 64 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 4. [Sunshield Chemicals Ltd](https://www.sectoralpha.in/stocks/sunshield-chemicals-ltd) SUNSHIEL · quiet · Evidence leans up · 81% evidence 63.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 12.9% · Profit 100% · Operating margin change 5 points · 88% evidence Capital efficiency 18.6/25 · ROCE 19.9% · Operating margin 16% · 100% evidence Valuation 10.8/20 · P/E 24.3× · PEG 2.21 · 100% evidence Relative strength 10.8/20 · Lead over its industry n/a · Lead over NIFTY 500 4.3% · 1 year -4% · 25% evidence · 0 of 5 weeks ahead Exact sum: 23.6 + 18.6 + 10.8 + 10.8 = 63.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) BLACKROSE · quiet · Evidence leans up · 81% evidence 60.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.6/35 · Revenue 8.6% · Profit 28.6% · Operating margin change 6 points · 88% evidence Capital efficiency 16.3/25 · ROCE 18.7% · Operating margin 16% · 100% evidence Valuation 10.0/20 · P/E 17.1× · PEG 4.96 · 100% evidence Relative strength 10.9/20 · Lead over its industry n/a · Lead over NIFTY 500 4.4% · 1 year n/a · 25% evidence · 7 of 12 weeks ahead Exact sum: 23.6 + 16.3 + 10 + 10.9 = 60.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Tatva Chintan Pharma Chem Ltd](https://www.sectoralpha.in/stocks/tatva-chintan-pharma-chem-ltd) TATVA · losing its lead · Evidence leans up · 93% evidence 59.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.7/35 · Revenue 49.2% · Profit 100% · Operating margin change 1 points · 100% evidence Capital efficiency 8.5/25 · ROCE 7.2% · Operating margin 19% · 100% evidence Valuation 11.3/20 · P/E 60.2× · PEG 1.21 · 65% evidence Relative strength 11.4/20 · Lead over its industry 7.8% · Lead over NIFTY 500 23.3% · 1 year 15.6% · 100% evidence · 10 of 12 weeks ahead Exact sum: 28.7 + 8.5 + 11.3 + 11.4 = 59.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Aether Industries Ltd](https://www.sectoralpha.in/stocks/aether-industries-ltd) AETHER · leader · Evidence leans up · 90% evidence 59.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.4/35 · Revenue 30.2% · Profit 28.4% · Operating margin change 1 points · 100% evidence Capital efficiency 12.7/25 · ROCE 11.9% · Operating margin 32% · 100% evidence Valuation 9.7/20 · P/E 85.1× · PEG n/a · 50% evidence Relative strength 14.8/20 · Lead over its industry 22.3% · Lead over NIFTY 500 38.6% · 1 year 114.4% · 100% evidence · 12 of 12 weeks ahead Exact sum: 22.4 + 12.7 + 9.7 + 14.8 = 59.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 8. [Privi Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/privi-speciality-chemicals-ltd) PRIVISCL · quiet · Evidence leans up · 82% evidence 59.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.7/35 · Revenue 17.5% · Profit 44.5% · Operating margin change -1 points · 95% evidence Capital efficiency 18.5/25 · ROCE 22.3% · Operating margin 26% · 76% evidence Valuation 10.1/20 · P/E 33.7× · PEG n/a · 50% evidence Relative strength 7.1/20 · Lead over its industry -9.7% · Lead over NIFTY 500 4.2% · 1 year 10.5% · 100% evidence · 2 of 12 weeks ahead Exact sum: 23.7 + 18.5 + 10.1 + 7.1 = 59.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Fineotex Chemical Ltd](https://www.sectoralpha.in/stocks/fineotex-chemical-ltd) FCL · leader · Evidence leans up · 96% evidence 59.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.3/35 · Revenue 91.5% · Profit 41% · Operating margin change -2 points · 88% evidence Capital efficiency 13.6/25 · ROCE 18.3% · Operating margin 16% · 100% evidence Valuation 5.7/20 · P/E 46.1× · PEG 1.92 · 100% evidence Relative strength 19.5/20 · Lead over its industry 34.1% · Lead over NIFTY 500 48.9% · 1 year 62.9% · 100% evidence · 12 of 12 weeks ahead Exact sum: 20.3 + 13.6 + 5.7 + 19.5 = 59.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 10. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) DMCC · quiet · Evidence leans up · 93% evidence 55.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.9/35 · Revenue 72.1% · Profit 34.5% · Operating margin change -6.9 points · 100% evidence Capital efficiency 8.6/25 · ROCE 14.8% · Operating margin 4.2% · 100% evidence Valuation 16.1/20 · P/E 16.9× · PEG 0.44 · 65% evidence Relative strength 7.8/20 · Lead over its industry -12.3% · Lead over NIFTY 500 0.9% · 1 year -15.5% · 100% evidence · 9 of 12 weeks ahead Exact sum: 22.9 + 8.6 + 16.1 + 7.8 = 55.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. [Aarti Industries Ltd](https://www.sectoralpha.in/stocks/aarti-industries-ltd) AARTIIND · quiet · Evidence leans up · 100% evidence 55.1 out of 100 Growth Capital Valuation Relative
12. [Galaxy Surfactants Ltd](https://www.sectoralpha.in/stocks/galaxy-surfactants-ltd) GALAXYSURF · leader · Evidence leans up · 81% evidence 53.7 out of 100 Growth Capital Valuation Relative
13. [Pidilite Industries Ltd](https://www.sectoralpha.in/stocks/pidilite-industries-ltd) PIDILITIND · quiet · Evidence leans up · 100% evidence 52.8 out of 100 Growth Capital Valuation Relative
14. [DIC India Ltd](https://www.sectoralpha.in/stocks/dic-india-ltd) DICIND · breaking out · Evidence leans up · 81% evidence 52.8 out of 100 Growth Capital Valuation Relative
15. [Neogen Chemicals Ltd](https://www.sectoralpha.in/stocks/neogen-chemicals-ltd) NEOGEN · leader · Evidence leans up · 90% evidence 51.7 out of 100 Growth Capital Valuation Relative
16. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) KRONOX · breaking out · Evidence leans up · 74% evidence 51.6 out of 100 Growth Capital Valuation Relative
17. Chemcon Speciality Chemicals Ltd this page CHEMCON · breaking out · Evidence leans up · 85% evidence 50.9 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 24.6/35 · Revenue 22.3% · Profit 20.2% · Operating margin change 4.1 points · 100% evidence Capital efficiency 8.6/25 · ROCE 6.3% · Operating margin 16.9% · 100% evidence Valuation 7.9/20 · P/E 22.2× · PEG 2.82 · 100% evidence Relative strength 9.8/20 · Lead over its industry n/a · Lead over NIFTY 500 1.7% · 1 year -25.8% · 25% evidence · 9 of 12 weeks ahead Exact sum: 24.6 + 8.6 + 7.9 + 9.8 = 50.9 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 18. [Grauer & Weil (India) Ltd](https://www.sectoralpha.in/stocks/grauer-weil-indialtd) GRAUWEIL · breaking out · Evidence leans down · 96% evidence 46.3 out of 100 Growth Capital Valuation Relative
19. [Paushak Ltd](https://www.sectoralpha.in/stocks/paushak-ltd) PAUSHAKLTD · losing its lead · Evidence leans down · 85% evidence 45.6 out of 100 Growth Capital Valuation Relative
20. [Alkyl Amines Chemicals Ltd](https://www.sectoralpha.in/stocks/alkyl-amines-chemicals-ltd) ALKYLAMINE · quiet · Evidence leans down · 96% evidence 45.5 out of 100 Growth Capital Valuation Relative
21. [Platinum Industries Ltd](https://www.sectoralpha.in/stocks/platinum-industries-ltd) PLATIND · turning · Evidence leans down · 81% evidence 45.5 out of 100 Growth Capital Valuation Relative
22. [Innovassynth Technologies (India) Ltd](https://www.sectoralpha.in/stocks/innovassynth-technologies-indialtd) breaking out · Too little evidence to rank firmly · 53% evidence 44.0 out of 100 Growth Capital Valuation Relative
23. [Anupam Rasayan India Ltd](https://www.sectoralpha.in/stocks/anupam-rasayan-india-ltd) ANURAS · turning · Evidence leans down · 78% evidence 43.7 out of 100 Growth Capital Valuation Relative
24. [Vinati Organics Ltd](https://www.sectoralpha.in/stocks/vinati-organics-ltd) VINATIORGA · quiet · Evidence leans down · 82% evidence 42.4 out of 100 Growth Capital Valuation Relative
25. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) AMNPLST · quiet · Evidence leans down · 81% evidence 42.3 out of 100 Growth Capital Valuation Relative
26. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) AMAL · quiet · Evidence leans down · 68% evidence 41.3 out of 100 Growth Capital Valuation Relative
27. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) TRANSPEK · losing its lead · Evidence leans down · 63% evidence 38.6 out of 100 Growth Capital Valuation Relative
28. [Vishnu Chemicals Ltd](https://www.sectoralpha.in/stocks/vishnu-chemicals-ltd) VISHNU · losing its lead · Evidence leans down · 100% evidence 38.2 out of 100 Growth Capital Valuation Relative
29. [Clean Science & Technology Ltd](https://www.sectoralpha.in/stocks/clean-science-technology-ltd) CLEAN · breaking out · Evidence leans down · 85% evidence 38.1 out of 100 Growth Capital Valuation Relative
30. [Thirumalai Chemicals Ltd](https://www.sectoralpha.in/stocks/thirumalai-chemicals-ltd) TIRUMALCHM · quiet · Most evidence points down · 68% evidence 27.4 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Speciality Chemicals](https://www.sectoralpha.in/sectors/speciality-chemicals), all 30 compared on one page. ## Which companies are close to Chemcon Speciality Chemicals in size? Chemcon Speciality Chemicals is the 26th largest of 30 Speciality Chemicals companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Amines & Plasticizers, Kronox Lab Sciences and Transpek Industry. Just below it: Amal, DMCC Speciality Chemicals and Black Rose Industries. ### Speciality Chemicals companies close in size

1. [Amines & Plasticizers Ltd](https://www.sectoralpha.in/stocks/amines-plasticizers-ltd) ₹782 crore
2. [Kronox Lab Sciences Ltd](https://www.sectoralpha.in/stocks/kronox-lab-sciences-ltd) ₹691 crore
3. [Transpek Industry Ltd](https://www.sectoralpha.in/stocks/transpek-industry-ltd) ₹682 crore
4. Chemcon Speciality Chemicals Ltd ₹666 crore
5. [Amal Ltd](https://www.sectoralpha.in/stocks/amal-ltd) ₹658 crore
6. [DMCC Speciality Chemicals Ltd](https://www.sectoralpha.in/stocks/dmcc-speciality-chemicals-ltd) ₹634 crore
7. [Black Rose Industries Ltd](https://www.sectoralpha.in/stocks/black-rose-industries-ltd) ₹491 crore

[All 30 Speciality Chemicals companies, largest first](https://www.sectoralpha.in/sectors/speciality-chemicals#all-companies)

### Companies close in size in other industries

1. [BEML Land Assets Ltd](https://www.sectoralpha.in/stocks/beml-land-assets-ltd) ₹667 crore · Construction & Contracting
2. [Axtel Industries Ltd](https://www.sectoralpha.in/stocks/axtel-industries-ltd) ₹666 crore · Infra - Engineering - General
3. Chemcon Speciality Chemicals Ltd ₹666 crore
4. [Shalimar Paints Ltd](https://www.sectoralpha.in/stocks/shalimar-paints-ltd) ₹666 crore · Building Materials - Paints
5. [VLS Finance Ltd](https://www.sectoralpha.in/stocks/vls-finance-ltd) ₹666 crore · Finance & Investments - Others

## What else do people ask about Chemcon Speciality Chemicals? ### What is Chemcon Speciality Chemicals's share price today? Chemcon Speciality Chemicals Ltd's share price is ₹193.84, −18.4% over the past year. The whole company is worth ₹709 Cr on the market. In the last 52 weeks it traded between ₹134 to ₹238; today it is 58% of the way up from the low, 1.1% below its 200-day average (as of 4 November 2026). ### What were Chemcon Speciality Chemicals's latest quarterly results? Chemcon Speciality Chemicals Ltd reported revenue of ₹65.5 Cr and net profit of ₹7.5 Cr for the Sep 2026 quarter. Revenue rose 21.9% and profit rose 30.8% compared with a year earlier. Earnings per share were ₹2.05. The operating margin was 16.9%, 4.1 percentage points higher than a year earlier (as of 4 November 2026). ### What is Chemcon Speciality Chemicals's market cap? Chemcon Speciality Chemicals Ltd's market capitalisation is ₹709 Cr at a share price of ₹193.84. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Chemcon Speciality Chemicals performing? Chemcon Speciality Chemicals Ltd's share price has been rising for 8 weeks. In its latest quarter, revenue rose 21.9% and profit rose 30.8% compared with a year earlier. Over the past 13 weeks it has done better than the NIFTY 500, for 11 weeks running (as of 4 November 2026). ### Will Chemcon Speciality Chemicals's share price go up? This page does not forecast Chemcon Speciality Chemicals Ltd's share price. What it shows instead: the share price is ₹193.84, and it has been rising for 8 weeks. Its P/E of 23.6× is higher than 30% of its own last 6 years (as of 4 November 2026). ### Who owns Chemcon Speciality Chemicals? Promoters own 74.5% of Chemcon Speciality Chemicals Ltd, foreign institutions 0.3%, domestic institutions 0.0% and the public 25.3% (latest quarter). No group of owners changed its stake by a full point over the last two years (as of 4 November 2026). ### Does Chemcon Speciality Chemicals have too much debt? No, Chemcon Speciality Chemicals Ltd has little debt: its debt is 0.11× its equity, and its operating profit is 15 times its interest bill. FY26 borrowings were ₹53.0 Cr against equity of ₹484 Cr. So the returns on this page come from the business, not borrowed money (as of 4 November 2026). ### Where is Chemcon Speciality Chemicals in its business cycle? Chemcon Speciality Chemicals Ltd's FY26 operating margin was 13.0%, against a 13-year range of 10.0% to 33.0%: the low end of its own range, which is often where recoveries start. The latest quarter was 16.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Chemcon Speciality Chemicals story? Biggest thing to watch: the price has already been rising for 8 weeks, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Chemcon Speciality Chemicals a stock worth studying right now? What the numbers show: Chemcon Speciality Chemicals Ltd's results are improving, while its P/E is near the low end of its own history over 6.1 years, higher than only 30% of past readings. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). ## Lists

- Dividend stocks: https://www.sectoralpha.in/dividend-stocks-india

This is research, not advice. We’re not SEBI-registered.